Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
11C-HY-2-15 PET in MSA, PD, and PSP
NCT06032026Phase 1Recruiting
- Sponsor
- University of Pennsylvania
- Start
- Jul 2023
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by University of Pennsylvania. Primary endpoints: Organ biodistribution at 4 weeks and PET uptake of tracer at 4 weeks. Started Jul 2023; status: recruiting.
Beyond the preview
Go deeper on NCT06032026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06032026.